Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug combination containing borneol

A composition and drug technology, applied in the field of medicine, can solve the problems of variable content of active ingredients, volatile, affecting curative effect, etc., and achieve the effects of good therapeutic effect, controllable quality and clear ingredients

Active Publication Date: 2012-12-26
HAINAN BIKAI PHARM CO LTD
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In the past ten years, traditional Chinese medicine represented by Baofukang Suppository (the main components are zedoary oil and borneol) has been widely used in the treatment of female reproductive tract HPV infection, and has achieved certain curative effect, but the zedoary oil used has complex components. , the content of active ingredients is variable and volatile, which obviously affects the curative effect; therefore, it is urgent to develop a pharmaceutical composition with clear ingredients and stable content to prevent and treat HPV infection and the benign or malignant lesions induced by it, especially for the HR of cervical cancer. -HPV infection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug combination containing borneol
  • Drug combination containing borneol
  • Drug combination containing borneol

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0172] Prescription: gemmaconone 13.9g, furadienes 39.4g, curdione 24g, β-elemene 9.7g, curcumol 0.5g, curcumene 0.5g, borneol 75g (the content of borneol in borneol is 90.0%) .

[0173] Dosage form: suppository.

[0174] Preparation method: mix the prescribed amount of gemmacone, furadienes, curdione, β-elemene, curcumol, curcumene with 70g of polysorbate 80, dissolve 75g of borneol with an appropriate amount of ethanol, and mix with the above solution Mix well.

[0175] The polyoxyethylene stearate 1524g of recipe quantity is put on the water bath and is heated and melted, adds above-mentioned medicinal liquid, stirs, filling, makes 1000 suppositories, each 1.74g.

Embodiment 2～8

[0177] Prepare the suppository according to the following prescription, the preparation method is the same as in Example 1, (the content of borneol in the borneol is 95.5%).

[0178] Example

[0179] β-Elemene

Embodiment 9

[0181] Prescription: Gemacerone 6.5g, Furandiene 32g, Curdione 21g, β-Elemene 8.5g, Curcumol 0.45g, Borneolum 35g (the content of borneol in the Borneolum is 96.3%).

[0182] Dosage form: effervescent tablet.

[0183] Preparation:

[0184] 1) Take β-cyclodextrin, add appropriate amount of water according to 25ml / g, stir to make it fully dissolved, and heat if necessary to obtain β-cyclodextrin solution; ene, curcumol, borneol 35g, diluted with absolute ethanol, slowly added to the β-cyclodextrin solution, continued to stir until a homogeneous phase was formed, placed in the refrigerator overnight, filtered with suction, washed 3 times with a small amount of petroleum ether, frozen, A white powder was obtained.

[0185] 2) Mix the above-mentioned white powder with 35g of borneol, 150g of citric acid and 160g of lactose; take another 120g of sodium bicarbonate and 160g of lactose, mix them evenly, and use 5% PVP absolute ethanol solution as a binder to granulate, at 50°C Dry,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Weightaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the technical field of medicines, and provides a drug combination containing borneol. The drug combination comprises germacrone, furanodiene, curdione, Beta-elemene, curcumenol, curzerene and borneol. The drug combination contains definite components which is controllable in quality; the drug combination can control the content of camphol in borneol so as to improve the plasma concentration and the mucous membrane absorption rate of the drug combination; the drug combination can be used for preparing suppository, ointments, capsules, effervescent tablets, gelata, lotion, film agents or foaming agents; and the drug combination can achieve an excellent therapeutic effect on diseases such as HR-HPV (High Risk-Human PapillomaVirus) and / or LR-HPV (Low Risk-Human PapillomaVirus) and cervical diseases, and is suitable for clinical wide application.

Description

technical field [0001] The invention belongs to the technical field of medicines, and in particular relates to a pharmaceutical composition containing gemmacone, furadienes, curdione, β-elemene, curcumol, curcumene and borneol. Background technique [0002] Human papillomavirus (HPV) is a kind of papillomavacuolating virus A belonging to Papovaviridae. It is a spherical DNA virus that can cause squamous epithelial proliferation of human skin and mucous membranes. At present, more than 130 kinds have been isolated, and different subtypes cause different clinical manifestations and invade different tissue parts. According to the classification of cancer, it can be divided into low-risk HPV and high-risk HPV. [0003] HR-HPV mainly includes 13 subtypes, which are closely related to the occurrence of cervical cancer and cervical squamous neoplasia (CIN). Persistent infection of the cervix with HR-HPV can develop into cervical cancer within 8 to 10 years, and "cervical cancer" ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/352A61P15/02A61P15/00A61P35/00A61K31/20A61K31/35A61K31/343A61K31/122A61K31/045
Inventor 陈容徐扬冯仲异史朝辉
Owner HAINAN BIKAI PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com